TITLE:
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

CONDITION:
Parkinson's Disease

INTERVENTION:
Carbidopa/levodopa/entacapone

SUMMARY:

      The CELC200A2401 study has been designed in order to evaluate the hypothesis that
      administering the combination carbidopa/levodopa/entacapone at the time that levodopa
      therapy is initiated results in a decrease in the risk of the development of motor
      complications for patients with Parkinson's disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 30 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  Clinical diagnosis of idiopathic Parkinson's disease

          -  Diagnosis of Parkinson's disease for no more than 5 years

        Exclusion Criteria:

          -  History, signs, or symptoms of atypical or secondary parkinsonism

          -  Presence at baseline of drug-related wearing-off symptoms, dyskinesia or other motor
             complications

          -  Levodopa exposure of more than 30 days or anytime within 8 weeks prior to visit 1

        Other inclusion/exclusion criteria applied to this study.
      
